3TR: a pan-European cross-disease research consortium aimed at improving personalised biological treatment of asthma and COPD

Eur Respir J. 2021 Oct 21;58(4):2102168. doi: 10.1183/13993003.02168-2021. Print 2021 Oct.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Asthma* / drug therapy
  • Cross-Sectional Studies
  • Humans
  • Pulmonary Disease, Chronic Obstructive* / drug therapy